James M. Thorburn - 14 Apr 2022 Form 4 Insider Report for Twist Bioscience Corp (TWST)

Role
Chief Financial Officer
Signature
/s/ William Solis, as Attorney-in-Fact for James M. Thorburn
Issuer symbol
TWST
Transactions as of
14 Apr 2022
Net transactions value
-$165,312
Form type
4
Filing time
18 Apr 2022, 16:12:34 UTC
Previous filing
05 Apr 2022
Next filing
26 Apr 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TWST Common Stock Options Exercise $40,600 +3,503 +7.5% $11.59 50,191 14 Apr 2022 Direct
transaction TWST Common Stock Options Exercise $37,328 +1,600 +3.2% $23.33 51,791 14 Apr 2022 Direct
transaction TWST Common Stock Options Exercise $40,443 +1,517 +2.9% $26.66 53,308 14 Apr 2022 Direct
transaction TWST Common Stock Sale $234,631 -5,493 -10% $42.71 47,815 14 Apr 2022 Direct F1, F2
transaction TWST Common Stock Sale $49,052 -1,127 -2.4% $43.52 46,688 14 Apr 2022 Direct F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TWST Employee Stock Option (right to buy) Options Exercise $0 -3,503 -12% $0.000000 25,827 14 Apr 2022 Common Stock 3,503 $11.59 Direct F4
transaction TWST Employee Stock Option (right to buy) Options Exercise $0 -1,600 -6.2% $0.000000 24,148 14 Apr 2022 Common Stock 1,600 $23.33 Direct F5
transaction TWST Employee Stock Option (right to buy) Options Exercise $0 -1,517 -3.8% $0.000000 38,864 14 Apr 2022 Common Stock 1,517 $26.66 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 24, 2021.
F2 Represents the weighted average sales price per share. The shares sold at prices ranging from $42.23 to $43.16 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
F3 Represents the weighted average sales price per share. The shares sold at prices ranging from $43.24 to $44.90 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
F4 25% of the shares subject to the option vested and became exercisable on April 23, 2019, and 1/48th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
F5 25% of the shares subject to the option vested and became exercisable on October 24, 2020, and 1/48th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
F6 20% of the shares subject to the option vested and became exercisable on October 31, 2019, and 1/60th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.